Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q4 EPS of ($0.73), $0.06 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.